Furthermore, these macrophages exhibited higher IL-15 and IL-18 expressions in individuals with diabetes and NASH (1.7-fold and 2-fold, both p < 0.05, respectively) [24] (Table 1). The gene discussed is IL15; the disease is metabolic dysfunction-associated steatohepatitis.